Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3345)
All Articles published online
|
Apr 14, 2008 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou YM, Wen YH, Kang XY, Qian HH, Yang JM, Yin ZF. Troglitazone, a peroxisome proliferator-activated receptor γ ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells. World J Gastroenterol 2008; 14(14): 2168-2173 [PMID: 18407589 DOI: 10.3748/wjg.14.2168] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i14/2168.htm |
| Number | Citing Articles |
| 1 |
Toshikatsu Okumura. Mechanisms by which thiazolidinediones induce anti-cancer effects in cancers in digestive organs. Journal of Gastroenterology 2010; 45(11): 1097 doi: 10.1007/s00535-010-0310-9
|
| 2 |
Valerio Pazienza, Manlio Vinciguerra, Gianluigi Mazzoccoli. PPARs Signaling and Cancer in the Gastrointestinal System. PPAR Research 2012; 2012: 1 doi: 10.1155/2012/560846
|
| 3 |
Jihan A. Youssef, Mostafa Z. Badr. Peroxisome Proliferator-Activated Receptors. 2013; : 33 doi: 10.1007/978-1-62703-420-3_5
|
| 4 |
P. J. Simpson-Haidaris, S. J. Pollock, S. Ramon, N. Guo, C. F. Woeller, S. E. Feldon, R. P. Phipps. Anticancer Role of PPARγAgonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes. PPAR Research 2010; 2010: 1 doi: 10.1155/2010/814609
|
| 5 |
Liwei Wu, Chuanyong Guo, Jianye Wu. Therapeutic potential of PPARγ natural agonists in liver diseases. Journal of Cellular and Molecular Medicine 2020; 24(5): 2736 doi: 10.1111/jcmm.15028
|
| 6 |
D Vara, C Morell, N Rodríguez-Henche, I Diaz-Laviada. Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma. Cell Death & Disease 2013; 4(5): e618 doi: 10.1038/cddis.2013.141
|
| 7 |
Emmanuelle Berger, Nathalie Vega, Hubert Vidal, Alain Geloën. Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survival. Biotechnology Journal 2012; 7(11): 1395 doi: 10.1002/biot.201200188
|
| 8 |
Jihan Youssef, Mostafa Badr. Peroxisome proliferator-activated receptors and cancer: challenges and opportunities. British Journal of Pharmacology 2011; 164(1): 68 doi: 10.1111/j.1476-5381.2011.01383.x
|
| 9 |
Feng Zhang, Yin Lu, Shizhong Zheng. Peroxisome proliferator-activated receptor-γ cross-regulation of signaling events implicated in liver fibrogenesis. Cellular Signalling 2012; 24(3): 596 doi: 10.1016/j.cellsig.2011.11.008
|
| 10 |
Radina Kostadinova, Franziska Boess, Dawn Applegate, Laura Suter, Thomas Weiser, Thomas Singer, Brian Naughton, Adrian Roth. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity. Toxicology and Applied Pharmacology 2013; 268(1): 1 doi: 10.1016/j.taap.2013.01.012
|
| 11 |
Tomoyuki Sato, Masahiro Segawa, Shuichi Sekine, Kousei Ito. Mild depolarization is involved in troglitazone-induced liver mitochondrial membrane permeability transition via mitochondrial iPLA<sub>2</sub> activation. The Journal of Toxicological Sciences 2019; 44(11): 811 doi: 10.2131/jts.44.811
|
| 12 |
Fereshteh Asgharzadeh, Arghavan Memarzia, Vida Alikhani, Sima Beigoli, Mohammad Hossein Boskabady. Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth. Translational Oncology 2024; 47: 102039 doi: 10.1016/j.tranon.2024.102039
|
| 13 |
Hui-Min Chen, Ding-Guo Zhang, Jin-Xiz Wu, Dong-Sheng Pei, Jun-Nian Zheng. Ubiquitination of p53 is Involved in Troglitazone Induced Apoptosis in Cervical Cancer Cells. Asian Pacific Journal of Cancer Prevention 2014; 15(5): 2313 doi: 10.7314/APJCP.2014.15.5.2313
|
| 14 |
Minqian Shen, Jingyi Cao, Haifei Shi. Effects of Estrogen and Estrogen Receptors on Transcriptomes of HepG2 Cells: A Preliminary Study Using RNA Sequencing. International Journal of Endocrinology 2018; 2018: 1 doi: 10.1155/2018/5789127
|
| 15 |
Swati Katoch, Vinesh Sharma, Vikram Patial. Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios. World Journal of Gastroenterology 2022; 28(28): 3535-3554 doi: 10.3748/wjg.v28.i28.3535
|
| 16 |
Qiang Yu, Liwei Wu, Jie Ji, Jiao Feng, Weiqi Dai, Jingjing Li, Jianye Wu, Chuanyong Guo. <p>Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma</p>. Journal of Hepatocellular Carcinoma 2020; : 271 doi: 10.2147/JHC.S277870
|
| 17 |
Pankaj Kumar Singh, Raj Kumar, Ashok Sharma, Rajesh Arora, Swatantra Kumar Jain, Rakesh Kumar Sharma. Pifithrin‐α decreases the radioprotective efficacy of a Podophyllum hexandrum (Himalayan mayapple) fraction (REC‐2006) in HepG2 cells. Biotechnology and Applied Biochemistry 2009; 54(1): 53 doi: 10.1042/BA20080250
|